Immunome
IMNM
IMNM
104 hedge funds and large institutions have $907M invested in Immunome in 2024 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
82% more funds holding
Funds holding: 57 → 104 (+47)
15.68% more ownership
Funds ownership: 50.32% → 66% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
104
Holding in Top 10
1
Calls
$1.71M
Puts
$816K
Top Buyers
1 | +$37.4M | |
2 | +$29.5M | |
3 | +$24.9M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.7M |
5 |
TCM
Tang Capital Management
San Diego,
California
|
+$17.8M |
Top Sellers
1 | -$11.3M | |
2 | -$1.87M | |
3 | -$1.32M | |
4 |
AGM
Alpine Global Management
New York
|
-$1.23M |
5 |
PCM
Prentice Capital Management
Greenwich,
Connecticut
|
-$1.2M |